Sponsor

Pharnext S.C.A.

Clinical research sponsor

Published trials2

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I CompletionNCT02361242 · lead sponsor · 2013-06-01

COMPLETED

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)NCT02361424 · lead sponsor · 2013-02-01

COMPLETED

Sponsor roles

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.